2
Total investments
0
Early stage
1
Mid stage
1
Late stage
8y
Years active
Portfolio
2 investments · sorted by recency
All investments
Early stage
Mid stage
Late stage
Board Member
Oct 2018
Klaria AB is a pharmaceutical company developing innovative pharmaceuticals for migraine, cancer-related pain and opioid overdoses.
Board member Intellego Technologies AB
May 2018
Intellego Technologies is a rapidly growing research and development company. Intellego’s main goal is to develop its patented dosimeter technology, which can indicate when radiation or substances are present. The dosimeter technology involves a photochromic ink which changes color when exposed to a certain level of radiation or certain substances. The application areas are widespread, and Intellego is today working with products for use in the consumer, hospital and construction industries. In addition, Intellego has several development projects for other applications in its pipeline. Intellego’s products are sold in 15 countries worldwide.
Experience · 5 entries
All (5)
Investments (2)
Board (2)
2023
Investment Director
Aug 2023
Investment AB Latour is the investment company investing in companies with their own products and with a great development potential based on key global megatrends to create a long-term sustainable value for its shareholders.
Latours operations are primarily carried out in two business lines, a wholly owned industrial operations and a portfolio of listed holdings.
Latour is an active principal owner in the companies, regardless of whether the holdings are listed, wholly-owned or part-owned, where the work of the Board is an important platform for the value creation.
2022
Associate Partner
Aug 2022
McKinsey & Company is a global management consulting firm. We are the trusted advisor to the worlds leading businesses, governments, and institutions.
We work with leading organizations across the private, public and social sectors. Our scale, scope, and knowledge allow us to address problems that no one else can. We have deep functional and industry expertise as well as breadth of geographical reach. We are passionate about taking on immense challenges that matter to our clients and, often, to the world.
We work with our clients as we do with our colleagues. We build their capabilities and leadership skills at every level and every opportunity. We do this to help build internal support, get to real issues, and reach practical recommendations. We bring out the capabilities of clients to fully participate in the process and lead the ongoing work.
2018
Board Member
Oct 2018
Klaria AB is a pharmaceutical company developing innovative pharmaceuticals for migraine, cancer-related pain and opioid overdoses.
Board member Intellego Technologies AB
May 2018
Intellego Technologies is a rapidly growing research and development company. Intellego’s main goal is to develop its patented dosimeter technology, which can indicate when radiation or substances are present. The dosimeter technology involves a photochromic ink which changes color when exposed to a certain level of radiation or certain substances. The application areas are widespread, and Intellego is today working with products for use in the consumer, hospital and construction industries. In addition, Intellego has several development projects for other applications in its pipeline. Intellego’s products are sold in 15 countries worldwide.
2011
A
Antell & Ardstål
Partner
Aug 2011
